Magnetic
resonance-guided focused ultrasound (MRgFUS) is a promising
non-invasive surgical technique with spatial specificity and minimal
off-target effects. Despite the expanding clinical applications, the
major obstacles associated with MRgFUS still lie in low magnetic resonance
imaging (MRI) sensitivity and safety issues. High ultrasound power
is required to resist the energy attenuation during the delivery to
the tumor site and may cause damage to the surrounding healthy tissues.
Herein, a surface modification strategy is developed to simultaneously
strengthen MRI and ultrasound ablation of MRgFUS by prolonging Fe3O4 nanoparticles’ blood circulation and
tumor-environment-triggered accumulation and retention at the tumor
site. Specifically, reactive oxygen species-labile methoxy polyethylene
glycol and pH-responsive DNA cross-linkers are modified on the surface
of Fe3O4 nanoparticles, which can transform
nanoparticles into aggregations through the cascade responsive reactions
at the tumor site. Notably, DNA is selected as the pH-responsive cross-linker
because of its superior biocompatibility as well as the fast and sensitive
response to the weak acidity of 6.5–6.8, corresponding to the
extracellular pH of tumor tissues. Due to the significantly enhanced
delivery and retention amount of Fe3O4 nanoparticles
at the tumor site, the MRI sensitivity was enhanced by 1.7-fold. In
addition, the ultrasound power was lowered by 35% to reach a sufficient
thermal ablation effect. Overall, this investigation demonstrates
a feasible resolution to promote the MRgFUS treatment by enhancing
the therapeutic efficacy and reducing the side effects, which will
be helpful to guide the clinical practice in the future.